Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jun 1;66(Suppl 4):S267–S274. doi: 10.1093/cid/cix1137

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 IGO (CC BY 3.0 IGO) License (https://creativecommons.org/licenses/by/3.0/igo/) which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 1. — Illustrative predicted trends in onchocerciasis microfilarial prevalence in different settings of endemicity with different past and future interventions. For full set of graphs, see Supplementary Data 2 and 3. Microfilarial prevalence projected by ONHCOSIM represents the mean per 1000 model runs. The projections are deterministic for EPIONCHO. Labeled future intervention strategies were simulated from 2019 to 2025 (vector control 15 years has vector control but not mass drug administration applied until 2035). A, Precontrol (baseline) microfilarial prevalence. B–D, 60% precontrol microfilarial prevalence. D, No history of control. Abbreviations: aMDA, annual mass drug administration; cov., coverage; fut. tr., future treatment; MDA, mass drug administration; mf, microfilariae; prev. = prevalence.